Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Treatment Approach Name | Crizotinib |
| Profile Name | EML4 - ALK ALK R1192P |
| Drug Class | |
| Therapy | Crizotinib |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (27009859) | TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors. | Full reference... |